Prodesse, Cepheid Set Distribution Pact | GenomeWeb

NEW YORK (GenomeWeb News) – Prodesse will distribute Cepheid’s SmartCycler System and related products in the US under a new non-exclusive agreement, Milwaukee, Wis.-based Prodesse said today.

Prodesse’s ProFlu+ Assay and three other assays have been cleared by the Food and Drug Administration for use with the SmartCycler, and other tests are in the pipeline, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.